319 related articles for article (PubMed ID: 12946842)
1. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.
Becker I; Salaiza N; Aguirre M; Delgado J; Carrillo-Carrasco N; Kobeh LG; Ruiz A; Cervantes R; Torres AP; Cabrera N; González A; Maldonado C; Isibasi A
Mol Biochem Parasitol; 2003 Aug; 130(2):65-74. PubMed ID: 12946842
[TBL] [Abstract][Full Text] [Related]
2. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
[TBL] [Abstract][Full Text] [Related]
3. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling.
de Veer MJ; Curtis JM; Baldwin TM; DiDonato JA; Sexton A; McConville MJ; Handman E; Schofield L
Eur J Immunol; 2003 Oct; 33(10):2822-31. PubMed ID: 14515266
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
5. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
6. Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.
Favila MA; Geraci NS; Jayakumar A; Hickerson S; Mostrom J; Turco SJ; Beverley SM; McDowell MA
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004238. PubMed ID: 26630499
[TBL] [Abstract][Full Text] [Related]
7. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
[TBL] [Abstract][Full Text] [Related]
8. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes.
Kelleher M; Curtis JM; Sacks DL; Handman E; Bacic A
Mol Biochem Parasitol; 1994 Aug; 66(2):187-200. PubMed ID: 7808469
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell function.
Ho JL; Kim HK; Sass PM; He S; Geng J; Xu H; Zhu B; Turco SJ; Lo SK
J Immunol; 1996 Oct; 157(7):3013-20. PubMed ID: 8816410
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major lipophosphoglycan: discrepancy in Toll-like receptor signaling.
Kavoosi G; Ardestani SK; Kariminia A; Alimohammadian MH
Exp Parasitol; 2010 Feb; 124(2):214-8. PubMed ID: 19769970
[TBL] [Abstract][Full Text] [Related]
11. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.
Kelleher M; Bacic A; Handman E
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):6-10. PubMed ID: 1370357
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.
Proudfoot L; Nikolaev AV; Feng GJ; Wei WQ; Ferguson MA; Brimacombe JS; Liew FY
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10984-9. PubMed ID: 8855295
[TBL] [Abstract][Full Text] [Related]
13. An antigenically distinct lipophosphoglycan on amastigotes of Leishmania major.
Glaser TA; Moody SF; Handman E; Bacic A; Spithill TW
Mol Biochem Parasitol; 1991 Apr; 45(2):337-44. PubMed ID: 1710036
[TBL] [Abstract][Full Text] [Related]
14. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.
Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP
Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: association of the differentially expressed gene B protein and the surface lipophosphoglycan as revealed by membrane capping.
Pimenta PF; Pinto da Silva P; Rangarajan D; Smith DF; Sacks DL
Exp Parasitol; 1994 Nov; 79(3):468-79. PubMed ID: 7957764
[TBL] [Abstract][Full Text] [Related]
16. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes.
Tonui WK; Ngumbi PM; Mpoke SS; Orago AS; Mbati PA; Turco SJ; Mkoji GM
East Afr Med J; 2004 Feb; 81(2):97-103. PubMed ID: 15125094
[TBL] [Abstract][Full Text] [Related]
18. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.
Chalifour A; Jeannin P; Gauchat JF; Blaecke A; Malissard M; N'Guyen T; Thieblemont N; Delneste Y
Blood; 2004 Sep; 104(6):1778-83. PubMed ID: 15166032
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan. Partial characterization of private and public epitopes.
Ilg T; Harbecke D; Wiese M; Overath P
Eur J Biochem; 1993 Oct; 217(2):603-15. PubMed ID: 7693464
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT; Sheasby CE; Tough DF
J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
